Chemotherapy-induced peripheral neuropathy Many first-line chemotherapy agents used in the current clinical practice, such as platinum-based anticancer drugs (i.e., cisplatin, oxaliplatin), proteasome/angiogenesis inhibitors (bortezomib/thalidomide), vinca alkaloids (i.e., vincristine, vinorelbine) and taxanes (i.e., paclitaxel, docetaxel) cause a dose-limiting side effect called chemotherapy-induced peripheral neuropathy (CIPN) (Han and Smith, 2013
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: A randomized, double-blind, placebo-controlled trial
It acts as a primary defense molecule that is used up quickly during times of physical stress
Blood tests can also determine whether supplementation is achieving the desired effect
It achieves this by preserving the length of telomeres and stimulating the production of telomerase
Featuring a pull a part design, these capsules also allow for the nutrients to be taken separately if needed